top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Women's Cancer Research Foundation
Aug 23, 20221 min read
Genetic Testing — A Game-Changer
Since 2003, when scientists successfully mapped the human genome, personalized cancer therapy has transformed cancer treatment.
0 comments
Women's Cancer Research Foundation
Aug 1, 20221 min read
Malnutrition As A Risk Factor for Post-operative Morbidity in Gynecologic Cancer
An article from Gynecologic Oncology reviewed the association between various malnutrition definitions with post-operative morbidity.
0 comments
Women's Cancer Research Foundation
Jul 26, 20222 min read
Prevention of Ovarian Cancer
Risk reduction for women who carry BRCA1/2 mutations can achieve a 95% reduced risk of ovarian cancer through a risk-reducing...
0 comments
Women's Cancer Research Foundation
Jul 20, 20221 min read
Liquid Biopsy in Ovarian Cancer
In recent years there have been considerable efforts to develop a blood test or liquid biopsy...
0 comments
Women's Cancer Research Foundation
Jun 28, 20222 min read
Daily Aspirin Offers No Benefit in Breast Cancer Survivors
A recent study reported that daily intake of aspirin does not appear to prevent a recurrence of invasive breast cancer.
0 comments
Women's Cancer Research Foundation
May 20, 20221 min read
Ovarian Cancer Incidence and Death in Women Undergoing Bilateral Salpingo-Oophorectomy
Magnitude of risk reduction obtained with bilateral salpingo-oophorectomy remains unclear and must be weighed against the potential risks of
0 comments
Women's Cancer Research Foundation
May 18, 20222 min read
A 2022 Physician's Guide to Hopes and Challenges of Cervical Cancer Eradication
Each year more than 14,000 women in the United States will be diagnosed with cervical cancer and more than 4,000 people will die from it.
0 comments
Women's Cancer Research Foundation
May 16, 20222 min read
When Ovarian Cancer Returns, Surgery May Be a Good Choice for Selected Patients
A recent clinical trial revealed that a secondary surgery followed by chemotherapy can improve survival compared to chemotherapy alone.
0 comments
Women's Cancer Research Foundation
Apr 25, 20222 min read
New Drug Combination Shown to be Effective for Patients with Advanced Ovarian Cancer
Ovarian cancer is the most lethal gynecologic malignancy. Novel approaches for relapsed ovarian cancer are necessary to improve survival.
0 comments
Women's Cancer Research Foundation
Apr 22, 20222 min read
Clinical Characteristics, Pregnancy Outcomes & Ovarian Function - A Retrospective Age-Matched Study
Researchers evaluated the prognosis and pregnancy outcomes of pregnancy-associated breast cancer, a rare disease with increasing incidence.
0 comments
Women's Cancer Research Foundation
Apr 19, 20221 min read
Lighting the Way for Improved Detection of Ovarian Cancer
Pafolacianine, an imaging drug that can help surgeons identify ovarian cancer lesions, has recently been accorded FDA approval.
0 comments
Women's Cancer Research Foundation
Mar 16, 20221 min read
Racial Disparities in Non-Recommendation of Adjuvant Chemotherapy in Ovarian Cancer
In a recent study from Gynecologic Oncology, the authors identified ovarian cancer patients who underwent primary surgery from 2004 to 2015.
0 comments
Women's Cancer Research Foundation
Mar 10, 20221 min read
Overall Survival and Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
In a recent JAMA study, researchers endeavored to determine if there were differences in overall survival among ovarian cancer patients...
0 comments
Women's Cancer Research Foundation
Mar 2, 20221 min read
Ovarian Cancer Update
Last year, an estimated 314,000 people worldwide developed ovarian cancer, a condition associated with a 50% mortality rate.
0 comments
Women's Cancer Research Foundation
Feb 11, 20222 min read
Certain Cancers Increase Stroke Risk, New Analysis Confirms
A 2021 systematic review from Journal of Cancer Survivorship revealed that people living with select cancers have a significantly higher...
0 comments
Women's Cancer Research Foundation
Dec 23, 20212 min read
Chemo Brain Is Real
“Chemo brain” refers to thinking that is sluggish or fuzzy. Essentially, this condition can interfere with executive functioning...
0 comments
Women's Cancer Research Foundation
Nov 24, 20211 min read
Clinical Complications of Chemotherapy and Patient-Reported Outcomes After Breast Reconstruction
In a 2021 study, 1881 patients who received either implant-based or autologous breast reconstruction following neoadjuvant or adjuvant...
0 comments
Women's Cancer Research Foundation
Nov 5, 20212 min read
Do Annual Screenings Reduce Risk of Death in Ovarian Cancer?
Ovarian cancer is an aggressive disease, with a 10-year survival rate of 35%.
0 comments
Women's Cancer Research Foundation
Nov 3, 20211 min read
Intrauterine Device May Reduce Ovarian Cancer Risk by 30%
Women who have ever used an intrauterine device (IUD) for birth control may have a 30% lower risk for ovarian cancer.
0 comments
Women's Cancer Research Foundation
Oct 30, 20212 min read
Genital Powder Use and Epithelial Ovarian Cancer
Beginning in 2014, several lawsuits were filed against companies with talc products (baby powder) on behalf of women with ovarian cancer.
0 comments
bottom of page